Clinical Epidemiology
Volume 16, 2024 - Issue
Open access
117
Views
0
CrossRef citations to date
0
Altmetric
REVIEW
Hospitalization Endpoint in Clinical Trials of Outpatient Settings: using Anti-SARS-COV-2 Therapy as an Example
Alhanouf Yousef Alnafisah1 Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia
https://orcid.org/0009-0007-5309-7204
Ahmed Fawaz Alkhalidi1 Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi ArabiaCorrespondence[email protected]
, Hanin Aljohani1 Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia
, Manal Almutairi1 Efficacy and Safety Evaluation Department, Benefit and Risk Evaluation Directorate, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia
, Adel Alharf2 Drug Sector, Saudi Food and Drug Authority (SFDA), Riyadh, Saudi Arabia
& Hadeel Alkofide3 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
https://orcid.org/0000-0002-5032-1895
Pages 357-365
|
Received 15 Feb 2024, Accepted 07 May 2024, Published online: 23 May 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.